Serum thymidine kinase 1 correlates to clinical stages and clinical reactions and monitors the outcome of therapy of 1,247 cancer patients in routine clinical settings
Yan Chen(Fujian Medical University), Ellen He(ITRI International), Minhua Hu(Guangzhou University of Chinese Medicine), Ji Zhou(ITRI International), Yingying Lin(Fujian Medical University), Sven Skog(ITRI International), Yun Xia(Nanyang Technological University), Xiaoli Li(Fujian Medical University), Ming Zhang(Yunnan Agricultural University), YanSong Chen(Fujian Medical University), Dedong Chen(Fujian Medical University), Mingang Ying(Fujian Medical University)
Cited by 55
Related Papers
The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints
|Cancer Discovery|2014|1.5k
Roles of circRNAs in the tumour microenvironment
|Molecular Cancer|2020|281
The Physiologic Role of CD19 Cytoplasmic Tyrosines
|Immunity|2002|145
MiR-103a-3p promotes tumour glycolysis in colorectal cancer via hippo/YAP1/HIF1A axis
|Journal of Experimental & Clinical Cancer Research|2020|139
Inflammation: A Novel Therapeutic Target/Direction in Atherosclerosis
|Current Pharmaceutical Design|2017|132